IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL5.91▼ 0.70% USD/MXN19.14▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP3,483▲ 3.77% USD/PEN3.45▲ 0.19% USD/ARS1,580▲ 0.93% USD/UYU40.61▲ 3.16% USD/PYG6,212▲ 2.34% USD/BOB11.64▲ 2.55% USD/DOP59.52▼ 0.80% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO36.62▼ 0.69% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 2.60% USD/TTD6.70▲ 2.00% EUR/BRL6.52▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL 5.91 ▼ 0.70% USD/MXN 19.14 ▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP 3,483 ▲ 3.77% USD/PEN 3.45 ▲ 0.19% USD/ARS 1,580 ▲ 0.93% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 2.55% USD/DOP 59.52 ▼ 0.80% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.22% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 ▼ 0.69% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 2.60% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.52 ▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74%
since 2009
Saturday, November 21, 2026

Society Life & Society

Brazilian Develops Pen That Detects Cancer During Surgery

By · · 3 min read
In the United States, Livia earned prominence in the scientific community by being among the leading scientists selected in 2018 to receive the renowned scholarship from the MacArthur Foundation
In the United States, Livia Schiavinato Eberlin earned prominence in the scientific community by being among the leading scientists selected in 2018 to receive the renowned scholarship from the MacArthur Foundation.

By Richard Mann, Contributing Reporter

RIO DE JANEIRO, BRAZIL – A 33-year-old Brazilian scientist has developed a type of pen capable of detecting tumor cells in a matter of seconds. Livia Schiavinato Eberlin holds a degree in Chemistry from the State University of Campinas (Unicamp) and, despite her youth, is already head of a research laboratory at the University of Texas in Austin, United States.

Four years ago, she began investigating a device capable of extracting molecules from human tissue and identifying the presence of cancerous cells in tissue material analyzed.

Free daily brief — no card needed
Get every Life & Society story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

The technology is under study but has already yielded promising results when used in the examination of 800 samples of human tissue.

The researcher, who has been living for ten years in the USA, where she earned her doctorate, is in Brazil this week to present the findings of her research at the Next Frontiers to Cure Cancer Congress, promoted annually by A.C. Camargo Cancer Center in the city of São Paulo.

In the United States, Livia Schiavinato Eberlin earned prominence in the scientific community by being among the leading scientists selected in 2018 to receive the renowned scholarship from the MacArthur Foundation, known as the “genius scholarship” for professionals with outstanding and creative performance in their area.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil's lower house takes up Lula's fiscal bill”

The US$625,000 award is for free use by scholars.

In an exclusive interview to a Brazilian news outlet, the researcher explained that the pen, named MacSpec Pen, aims to ensure, during an oncological surgery, that all of the tumor tissue has been removed from the patient’s body.

RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

This is due to the fact that it is not always possible to visualize the boundary between the cancerous damage and the healthy tissue, to the naked eye.

“Often the tissue is removed and examined by a pathologist during surgery to confirm that the entire tumor was removed, but this process takes 30 to 40 minutes during which the patient remains exposed to anesthesia and other surgical risks,” explains Livia Schiavinato Eberlin.

The pen she and her team of researchers developed uses a chemical examination technique to provide the same response that a pathologist would do.

“The pen has a water-filled reservoir. When its tip touches the tissue, it captures molecules that dissolve in water and are transported to a mass spectrometer, a piece of equipment that distinguishes the sample as cancerous or not,” explains the scientist.

This classification of the sample as malignant or non-malignant can be done because the technology uses artificial intelligence techniques, apart from the chemical examination equipment, for the machine to “respond” when the cells are malignant.

To this end, hundreds of cancerous tissue samples were used in the development of the model, which, through their characteristics, “teach” the machine to identify tumor tissue.

“In the first phase of the research we analyzed over 200 human tissue samples and verified a 97 percent cancer identification accuracy,” says Livia.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.